1.
Nurlatipah E, Ratih L D, Subhan A, Sarwanti S. Evaluation Of The Effect Of Trastuzumab And Non-Trastuzumab Therapy On Overall Survival And Prognosis Of HER2-Positive Breast Cancer At Fatmawati Hospital Jakarta 2019-2024. HRJI [Internet]. 28 Juni 2026 [dikutip 7 Juli 2026];4(5):1251-6. Tersedia pada: https://wpcpublisher.com/jurnal/index.php/HRJI/article/view/1404